69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] VICCURO1260 03/19/2013 [Summary] A Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients with Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy [Trial Type] 
Treatment Prostate
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type